Hypoxia Modifies Proliferation and Differentiation of CD34 + CML Cells
Open Access
- 1 July 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 20 (4) , 347-354
- https://doi.org/10.1634/stemcells.20-4-347
Abstract
We previously showed that hypoxia (1% O2) favors the self-renewal of murine and human normal hematopoietic stem cells. This study represents the first attempt to characterize the effects of hypoxia on the maintenance of chronic myeloid leukemia (CML) progenitors. CD34+ cells isolated from apheresis products of CML patients were incubated in hypoxia (1% O2) and normoxia (20% O2). After 8 days of culture, their proliferation, capacity for colony-forming-cell (CFC) generation in secondary cultures (pre-CFC), and phenotype (CD34 and platelet-activating factor receptor [PAF-R]) were compared with those of normal cells, and tyrosine phosphorylation in CML cells was measured. Hypoxia inhibits the proliferation of CD34+ cells and preserves the pre-CFC capacity and cell-surface CD34 expression of CML cells better than normoxia. The PAF-R expression, which was absent on freshly isolated cells, was detected at the cell surface in both populations after 8 days of culture, but with a lower percentage of positive cells in CML cell cultures. Incubation in hypoxia suppressed the PAF-R expression of normal cells and increased it in CML cells, resulting in a similar expression in the two populations. These effects could be linked to inhibition by hypoxia of the tyrosine hyperphosphorylation of cellular proteins, a major hallmark of CML cells.Keywords
This publication has 16 references indexed in Scilit:
- Hypoxia maintains and interleukin-3 reduces the pre–colony-forming cell potential of dividing CD34+ murine bone marrow cellsExperimental Hematology, 2002
- Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percentTransfusion, 2000
- Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor–induced proliferation and maturationExperimental Hematology, 2000
- The molecular biology of chronic myeloid leukemiaBlood, 2000
- Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow‐repopulating ability together with the expansion of committed progenitorsBritish Journal of Haematology, 2000
- Expression of Platelet‐Activating Factor Receptor Transcript‐1 but Not Transcript‐2 by Human Bone Marrow CellsThe International Journal of Cell Cloning, 1999
- Effect of platelet‐activating factor on the growth of human erythroid and myeloid CD34+ progenitorsMediators of Inflammation, 1998
- Platelet-activating factor receptorJournal of Lipid Mediators and Cell Signalling, 1995
- Two different promoters direct expression of two distinct forms of mRNAs of human platelet‐activating factor receptorFEBS Letters, 1993
- Tyrosine Kinase Activity and Transformation Potency of bcr-abl Oncogene ProductsScience, 1990